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ABSTRACT 
Benign prostatic hypertrophy (B.P.H) is a common condition in men above 50 years of age & is 
characterized by a non malignant enlargement of the prostate resulting from excessive cellular growth of 
both the glandular and the stromal elements of the gland. The clinical feature of B.P.H. includes incomplete 
emptying, frequency, intermittency, weak stream, straining & nocturea. Modern treatment though effective 
in treating symptoms has a number of side effects such as Sexual dysfunction, Postural hypotension, 
Asthenia and Dizziness etc. Similarly, surgical procedures such as prostatectomy, laser treatment & 
transurethral resection of the prostate (TURP) are costly & associated with a high risk of complications and 
morbidity. Hence, there is definite need to explore and evaluate the efficacy of Ayurvedic medicines in the 
management of B.P.H. 
This B.P.H can be correlated with Vata-ashthila, described by Sushruta. Herbal drugs mentioned in the 
management of Vata-ashthila not only take care of symptoms but also aims to break the pathology & 
improves quality of life of patient. So, this clinical study was done to establish an Ayurvedic conservative 
treatment for B.P.H – Grade I & II, which is cost effective, free from adverse reactions and side effects of 
Allopathic drugs.  
An open randomized controlled clinical trial was conducted with Group A (phytotherapy) comprised of 
Ghana of Ashwagandha, Varun, Gokshur, Haritaki & Punarnava, whereas, in Group B - 1 blocker 
(Tamsulosin hydrochloride) was selected. 
The comparative analysis of results in both Group-A & B, revealed that the total effect of the therapy was 
same in both the groups. In Group A, 26.66% patients were Cured, 63.33% were relieved, 10% patients 
were markedly improved. Similarly, in Group B, 30% patients were Cured, 66.66% were relieved, 3.33% 
patients were markedly improved. This proves that the Phytotherapy combination does give the patients 
the same expected relief like modern drug i.e. Tamsulosin hydrochloride.  
KEYWORDS: Benign Prostatic Hypertrophy,  1 blocker- Tamsulosin hydrochloride, Sushrut Samhita-Vata 
ashthila, Ashwagandha, Varun, Gokshur, Haritaki, Punarnava. 
INTRODUCTION
 Benign prostatic hyperplasia (B.P.H) is a common 
condition in men above 50 years of age & is characterized 
by a non malignant enlargement of the prostate resulting 
from excessive cellular growth of both the glandular and 
the stromal elements of the gland.[1] It is a common 
condition in older men; approximately 50% of men aged 
60 years and 90% of those aged 85 years present with 
BPH. In India, prostatic hypertrophy is common over the 
age of 60 years.[2] 
 The aetiology of B.P.H. is unknown. One 
hypothesis infers that the prostate converts testosterone 
to a more powerful androgen, Dihydrotestosterone (DHT) 
which stimulates cell growth in the tissue that lines the 
prostate gland (the glandular epithelium) and is the major 
cause of the rapid prostate enlargement.[3]  
 Due to the enlargement of prostate gland, a group 
of symptoms develop which are called as prostatism. The 
clinical feature of B.P.H. includes incomplete emptying, 
frequency, intermittency, weak stream, straining & 
nocturea. For Curative relief – 5 alpha reductase inhibitors 
like Finasteride and Dutasteride whereas, for Symptomatic 
relief – Alpha blockers like Terazosin, Doxazosin, 
Tamsulosin, and Alfuzosin is given. However, long-term 
therapy is required to maintain the benefits these 
medicines, along with side effects and adverse effects like 
Sexual dysfunction, Postural hypotension, Asthenia and 
Dizziness etc.[4]  
 Further, there are various surgical procedures like 
prostatectomy, laser treatment & microwave treatment. 
However, transurethral resection of the prostate (TURP) 
has been the mainstay of treatment. But, surgery is 
associated with a high risk of complications and morbidity, 
including haemorrhage, infection, epididymitis, renal 
failure, stricture of the bladder neck, impotence etc. 
Additionally, about 20 to 25% of patients do not have a 
long-term satisfactory outcome surgery.[5]  
 This provides opportunity to Ayurvedic fraternity 
to explore and evaluate the efficacy of herbal drugs in the 
management of B.P.H. Ayurveda looks at this senile 
problem in a different way. There is a lot of similarity 
between Vata-ashthila described by Sushruta and Benign 
Prostatic Hyperplasia. Vata-ashthila is said to develop due 
to vitiated Vata which gets lodged in the space between 
Basti and Guda and gives rise to a hard, thick cystic 
(Granthi sadrushya) structure which is non shifting in 
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character and produces various obstructive and irritative 
urinary symptoms and cause pain in the bladder.[ 6, 7, 8] 
 Herbal drugs advocated in Ayurvedic texts not 
only takes care of symptoms of B.P.H. but also aims to 
break the pathology & improves quality of life of patient. 
Hence, this study was conducted to evaluate efficacy of 
Phytotherapy treatment comprising Ghana of 
Ashwagandha, Varun, Gokshur, Haritaki & Punarnava in the 
patients of B.P.H. (Grade I & II). The statistics revealed that 
the Phytotherapy combination effectively reduced the 
symptoms of B.P.H. & works out as good as the highly 
selective  1 blocker (Tamsulosin hydrochloride). 
AIMS AND OBJECTIVES 
1. The study primarily aims at evaluating the treatment’s 
result in B.P.H. (Grade I & II). 
2. To establish an Ayurvedic conservative treatment for 
B.P.H – Grade I & II, which is cost effective, free from 
adverse reactions and side effects of Allopathic drugs. 
MATERIALS AND METHODS  
Type of study- Open Randomized Controlled Clinical Trial 
Centre of study- Dr. D.Y.Patil Ayurvedic Hospital, Navi 
Mumbai, India.  
Sample size – 60 patients (30 in each group) 
Grouping of the patients – Randomly selected patients 
were divided into two groups  
Group A –Phytotherapy combination,  
Dose-Two tablets twice a day with Luke warm water.  
Group B – Capsule of Tamsulosin Hydrochloride,  
Dose- 1 Capsule of 0.4 mg at night.  
Duration of treatment - 3 months  
Follow Up – Every 3 weeks  
 
 
Drug profile 
Group A - Phytotherapy combination. The ingredients of 
this herbal formulation are. 
1. Ashwagandha Ghana (Withania somnifera) -100mg 
2. Varun Ghana (Crataeva Nurvela) -100mg  
3. Gokshura Ghana (Tribulis Terrestris) -100mg  
4. Haritaki (Terminalia chebula) -100mg 
5. Punarnava (Boerhavia Diffusa) -100mg 
All above mentioned herbal drugs taken in specified 
quantity and Ghan vati is prepared.  
Group B – Tamsulosin hydrochloride (Symptomatic relief 
– Alpha blockers) 
Criteria for the Selection of the Patients  
Inclusive criteria 
 Male patients about the age of 50 yrs  
 Prostate size - Grade I & II 
Exclusive criteria  
 Complicated B.P.H with Grade III 
 Ca’ prostate  
 Diabetes Mellitus  
 Oliguria  
 Stricture Urethra  
 Major disease like HIV, Liver cirrhosis, Koch’s, IHD, 
Nephrotic syndrome etc.  
Baseline Assessment & Investigations  
Investigations 
 CBC, ESR, BSL, BUN, Sr. creatinine, Urine R/M etc.  
 Digital rectal examination (DRE)  
 USG for prostate to observe weight and size of the 
prostate  
 Post- void residual urine volume (before and after 
treatment). 
 P.S.A (Prostate specific antigen)  
 AUA Score (American Urological Association 
Symptom Score) 
Table 1: Parameters of American Urological Association (A.U.A) Symptom Score 
Sr. No. Symptoms  Not at all Less than 1 
in 5 times  
Less than 
1/2 the time 
About 1/2 
the time 
More than 
½ time  
Almost 
always  
1 Incomplete emptying  0 1 2 3 4 5 
2 Frequency  0 1 2 3 4 5 
3 Intermittency  0 1 2 3 4 5 
4 Urgency  0 1 2 3 4 5 
5 Weak stream  0 1 2 3 4 5 
6 Straining  0 1 2 3 4 5 
7 Nocturea 0 1 2 3 4 5 
Total score 
1. 0-7 : Mildly symptomatic  
2. 8-19 : Moderately symptomatic  
3. 20-35 : Severely symptomatic  
Assessment of Efficacy of Therapy  
 The assessment of effect of therapy was totally 
based on the standard AUA symptom score. Symptomatic 
relief of the patient was the main aim. The effect of therapy 
was assessed in terms of Cured, Relieved, Markedly 
improved, Improved, and Unchanged.  
1. Cured – 100% relief, in all symptoms was considered 
as totally cured.  
2. Relieved – 75% to 100% relief in the symptoms  
3. Markedly Improved – 50% to 75% relief in the 
symptoms  
4. Improved – 25% to 50% relief in the symptoms  
5. Unchanged – Less than 25% or no relief symptoms 
was considered as unchanged.  
Method 
 A good clinical examination was done and patients 
with Grade I & II of B.P.H were selected in the study 
randomly. After starting the treatment, patients were 
called for visit after 1 week and patients were asked for 
the compliance of the tablet and side effects or the adverse 
effect if any, faced by the patients. No such adverse effects 
were found and so the treatment was then continued and 
patient was thoroughly examined in every 3 weeks. The 
AUA Score was assessed and a Digital rectal examination 
was carried out in 3 weeks. Statistical analysis was done 
from the data obtained final results were found out. The 
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Institutional Ethical Committee clearance reference 
number for this study is DYPUSA/16/12. 
STATISTICAL ANALYSIS 
A) Parametric tests for objective Parameters (Quantitative 
Data i.e. Improvement in Physical parameters & 
improvement in hematological parameters)  
B) Non –Parametric test for subjective parameters 
(Qualitative Data i.e. Relief in Symptoms)  
OBSERVATION  
 The Statistical analysis of symptoms of patients of 
B.P.H in Group- A, by Wilcoxon – matched – pairs Signed – 
ranks test is as below. 
Table 2: Statistical analysis of symptoms of patients of B.P.H in Group- A 
Sr. No Symptoms  Mean SD Diff 
SE 
Sum of all 
signed ranks 
No. of 
pairs 
Value 
of ‘Z’ 
P 
1 Incomplete 
Emptying  
BT 1.5 1.59 0.27 136 16 3.51 <0.001 Highly 
Significant AT 0.1 0.40 
DIFF 1.4 1.52 
2 Frequency  BT 3.16 0.93 0.16 465 30 4.78 <0.001 Highly 
Significant AT 0.8 0.71 
DIFF 2.36 0.92 
3 Intermittency  BT 1.26 1.48 0.22 136 16 3.51 <0.001 Highly 
Significant AT 0.13 0.43 
DIFF 1.13 2.25 
4 Urgency  BT 2.86 1.43 0.21 406 28 4.62 <0.001 Highly 
Significant AT 0.36 0.61 
DIFF 2.5 1.19 
5 Weak stream  BT 1.93 1.38 0.21 276 23 4.19 <0.001 Highly 
Significant AT 0.23 0.50 
DIFF 1.7 1.20 
6 Straining  BT 1.33 1.42 0.19 153 17 3.62 <0.001 Highly 
Significant AT 0.23 0.50 
DIFF 1.1 1.09 
7 Nocturea BT 2.93 1.52 0.20 406 27 4.87 <0.001 Highly 
Significant AT 0.7 0.79 
DIFF 2.23 1.13 
The Statistical analysis of symptoms of patients of B.P.H in Group- B, by Wilcoxon – matched – pairs Signed – ranks test is 
as below: 
Table 3: Statistical analysis of symptoms of patients of B.P.H in Group- B 
Sr. No Symptoms  Mean SD Diff 
SE 
Sum of all 
signed ranks 
No. of 
pairs 
Value 
of ‘Z’ 
P 
1 Incomplete 
Emptying  
BT 1.6 1.45 0.23 171 18 3.72 <0.001 Highly 
Significant AT 0.2 0.40 
DIFF 1.4 1.27 
2 Frequency  BT 3.43 0.93 0.11 465 30 4.78 <0.001 Highly 
Significant AT 0.93 0.73 
DIFF 2.5 0.62 
3 Intermittency  BT 1.26 1.20 0.20 153 17 3.62 <0.001 Highly 
Significant AT 0.06 0.25 
DIFF 1.2 1.12 
4 Urgency  BT 2.6 1.03 0.20 406 28 4.62 <0.001 Highly 
Significant AT 0.2 0.40 
DIFF 2.4 1.10 
5 Weak stream  BT 2.16 1.14 0.16 351 26 4.45 <0.001 Highly 
Significant AT 0.3 0.53 
DIFF 1.86 0.89 
6 Straining  BT 1.93 1.14 0.18 351 26 4.45 <0.001 Highly 
Significant AT 0.16 0.37 
DIFF 1.76 1.00 
7 Nocturea BT 2.8 1.12 0.14 406 28 4.62 <0.001 Highly 
Significant AT 0.56 0.67 
DIFF 2.23 0.81 
 Int. J. Ayur. Pharma Research, 2017;5(3):8-13 
 IJAPR | March 2017 | Vol 5 | Issue 3  11 
RESULT  
 Comparative analysis of results in both Group-A & B, revealed that the total effect of the therapy was same in both 
the groups. Total effect of the therapy in Group A, 8 patients (26.66%) were Cured, 19 (63.33%) were relieved, 3 (10%) 
were markedly improved. In Group B, 9 patients (30%) were Cured, 20 (66.66%) were relieved, 1 (3.33%) was markedly 
improved. This shows that the Phytotherapy combination does give the patients the same expected relief like modern drug 
i.e., Tamsulosin hydrochloride.  
Table 4: Table showing comparative results both in Group- A & B, using Wilcoxon Test 
Sr. No Symptoms  Group A Group B 
1 Incomplete Emptying  3.51 P<0.001 3.72 P<0.001 
2 Frequency  4.78 P<0.001 4.78 P<0.001 
3 Intermittency  3.51 P<0.001 3.62 P<0.001 
4 Urgency  4.62 P<0.001 4.62 P<0.001 
5 Weak stream  4.19 P<0.001 4.45 P<0.001 
6 Straining  3.62 P<0.001 4.45 P<0.001 
7 Nocturea 4.87 P<0.001 4.62 P<0.001 
Assessment of objective parameters 
 This assessment of study was based on the 
improvement in AUA Score. The parameters considered 
were Incomplete Emptying, Frequency, Intermittency, 
Urgency, Weak stream, Straining and Nocturea exclusively. 
However, surprisingly observed improvement in some 
other objective parameters like BUN, Weight of prostate, 
Post Void Residual Urine Volume (PVR) with Group A. 
These findings, though, not relevant to study, as they were 
not included as parameters to be studied, still they are 
mentioned here in brief, just to reveal the significance of 
Phytotherapy. 
1. BUN- Mean BUN level in Group A, before treatment was 
18.52 + 3.23 and after treatment was 18.33 + 2.29 where t 
= 0.68, P > 0.05, which was statistically insignificant.  
2. Weight of prostate- Mean Wt of prostate in gms in 
Group A, before treatment was 33.74 + 11.24 and after 
treatment was 33.72 + 11.26 where t = 1, P > 0.05, which 
was statistically insignificant. 
3. Post Void Residual Urine Volume (PVR)- Mean PVR in 
ml in Group A, before treatment was 64.4 + 59.71 and after 
treatment was 29.9 + 37.59 where t = 7.99, P > 0.001, 
which was statistically significant. 
DISCUSSION  
 Patients were asked for the follow up for 6 
months. For 3 months they were on medicine & for the 
remaining 3 months without medicine for the follow up. 
 In the data collected, majority of the patients were 
found in between 60-70 years 32 patients (53.33%). This 
shows that B.P.H is a geriatric problem. Out of 60 patients 
observed 34 patients (56.66%) were retired people. This 
shows that B.P.H is the disease of retirement.  
Group A: Phytotherapy combination - The patients of 
Group- A were found to have complete symptomatic relief. 
No adverse effects were observed in Group -A patients. 
Further, they did not have any recurrence of the symptoms 
after stopping the treatment.  
 This Phytotherapy combination has already 
proven its symptomatic relief in the patients of B.P.H 
(Grade I & II) in this study, but further evaluation should 
be done by taking a large sample size and giving the 
treatment for a longer period of a time to assess its efficacy 
in also reducing the size and weight of the prostate to 
establish drug for curative relief.  
Group B: Alpha blocker-Tamsulosin Hydrochloride- In 
order to avoid the side effect, postural hypotension etc. the 
patients were advised to take the capsule at the bed time. 
Dizziness was seen in some patients, but that did not 
disturb the routine work of the patient much. 
 Patients’ showed satisfactory relief during the 
treatment but after stopping the treatment, symptoms re 
occurred in most of them which reveals that long term 
therapy is required in Group- B category.  
Probable mechanism of Action of Phytotherapy  
Ashwagandha (Withania somnifera) – The drug is Kapha-
Vata shamak and effective in Granthishotha and 
Mootraghata like condition.[9]  
Previous research work reveals that Ashwagandha plays 
main role in reducing prostatic congestion &regularizes 
hormonal metabolism. It has immunomodulatory effect on 
prostate & Suppresses Androgen biosynthesis. [10, 11, 12] 
Varun (Crataeva nurvela)- It is KaphaVata -shamaka 
Pittavardhak, effective in Vranshoth, Vidradhi, Gulma, 
Ashmari, Bastishool and Mootrakrichra.[13]  
Research conducted proves that it exhibits 5-α reductase 
enzyme inhibitory activity. It also has Lithotriptic, Diuretic, 
Disinfectant, Anti inflammatory action.[14, 15, 16]  
Gokshura (Tribulis terrestris) - Gokshur is Vata Pitta –
shamaka, effective in conditions such as Nadidaurbalya, 
Ashmari, Mootrakrichra Bastishoth.[17] 
 It exhibits 5-α reductase enzyme inhibitory 
activity. It acts on the mucous membrane of the urinary 
tract. It contains potassium and other salts which increases 
volume of urine.[18, 19, 20] 
Haritaki (Terminalia chebula)- Haritaki is Tridosha –
shamaka, specially Vatashamaka, effective in Shoth, 
Ashmari, Vedanayuktavikara, Vrana, shoola, Gulma, 
Mootrakrichchra and Mootraghata. According to Ayurvedic 
concepts it is the best ‘Vatanulomak’ drug. [21] 
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This drug is Diuretic, Anti-inflammatory, Antiseptic, 
Antimicrobial, Antifungal Antibacterial, Antispasmodic.[22, 
23, 24]  
Punarnava (Boerhavia diffusa)- It posses Tridosha –
shamaka property and effective in Shoth and 
Mootrakrichchra.[25]  
 It contains alkaloids, ß-sitosterol, ursolic acid, 
Vitamins D, and E. It helps to regulate production of 
polyamine and prostaglandins which are powerful 
immuno-suppressants produced in the prostate& also 
support and balance the healthy flow of urine by toning 
smooth muscles located in the urino-genital system and 
reducing inflammation of the urethra and prostate. [26, 27] 
 Limitation & Scope for further research 
 This Phytotherapy combination has already 
proven its symptomatic relief in the patients of B.P.H 
(Grade I & II) in this study, but further evaluation should 
be done by taking a large sample size to observe any 
untoward effects. 
 There is a need to evaluate the efficacy of this 
combination in reducing the size and weight of the 
prostate giving curative relief along with the symptomatic 
relief to the patients of Benign Prostatic Hyperplasia.  
CONCLUSION  
 The phytotherapy combination gave remarkable 
results by reducing the symptoms of B.P.H. The statistics 
obtained clearly shows that the Phytotherapy combination 
works out as good as the highly selective  1 blocker, 
Tamsulosin hydrochloride. The number of patients Cured, 
Relieved, Markedly improved and Improved were almost 
equal in number. 
 From the results obtained in the study we can 
conclude that The Phytotherapy combination gives 
significant improvement in the AUA symptom score, 
increase in the urine flow rate, increase in the void volume 
and decrease in the post void residual urine volume. 
Furthermore, it relieves irritative symptoms like increased 
urine frequency, urgency and nocturea. Similarly, it 
relieves obstructive symptoms like hesitancy, poor and 
intermittent flow and incontinence. It also prevents U.T.I 
associated with B.P.H, safe with no adverse effects, cost 
effective as compared to modern drugs and improves the 
quality of life of patient with B.P.H. 
 Further research is needed using standardized 
preparations of Phytotherapy combination to determine 
its long-term effectiveness and ability to prevent BPH 
complications. 
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